Evidence map›Paper›PMID 30236160›Full record

ArticleParasites & vectors2018

Changes in the immune system in experimental acanthamoebiasis in immunocompetent and immunosuppressed hosts.

Natalia Łanocha-Arendarczyk, Agnieszka Kolasa-Wołosiuk, Iwona Wojciechowska-Koszko, Karolina Kot, Paulina Roszkowska, Barbara Krasnodębska-Szponder, Edyta Paczkowska, Bogusław Machaliński, Karolina Łuczkowska, Barbara Wiszniewska and 1 more

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Experimental Granulomatous Amebic Encephalitis Caused byTropical medicine and infectious disease · 2024
    Article
  6. Article
  7. Concentrations of PGEPathogens (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. FulminantOpen forum infectious diseases · 2020
    Article
  12. Article
  13. Interleukin (IL)-21 in Inflammation and Immunity During Parasitic Diseases.Frontiers in cellular and infection microbiology · 2019
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Natalia Łanocha-ArendarczykDepartment of Biology and Medical Parasitology, Pomeranian Medical University in Szczecin, 70-204, Szczecin, Poland.
Agnieszka Kolasa-WołosiukDepartment of Histology and Embryology, Pomeranian Medical University in Szczecin, 70-204, Szczecin, Poland.
Iwona Wojciechowska-KoszkoDepartment of Microbiology, Immunology and Laboratory Medicine, Pomeranian Medical University in Szczecin, 70-204, Szczecin, Poland.
Karolina KotDepartment of Biology and Medical Parasitology, Pomeranian Medical University in Szczecin, 70-204, Szczecin, Poland.
Paulina RoszkowskaDepartment of Microbiology, Immunology and Laboratory Medicine, Pomeranian Medical University in Szczecin, 70-204, Szczecin, Poland.
Barbara Krasnodębska-SzponderDepartment of Microbiology, Immunology and Laboratory Medicine, Pomeranian Medical University in Szczecin, 70-204, Szczecin, Poland.
Edyta PaczkowskaDepartment of General Pathology, Pomeranian Medical University in Szczecin, 70-204, Szczecin, Poland.
Bogusław MachalińskiDepartment of General Pathology, Pomeranian Medical University in Szczecin, 70-204, Szczecin, Poland.
Karolina ŁuczkowskaDepartment of General Pathology, Pomeranian Medical University in Szczecin, 70-204, Szczecin, Poland.
Barbara WiszniewskaDepartment of Histology and Embryology, Pomeranian Medical University in Szczecin, 70-204, Szczecin, Poland.
Danuta Kosik-BogackaDepartment of Biology and Medical Parasitology, Pomeranian Medical University in Szczecin, 70-204, Szczecin, Poland. kodan@pum.edu.pl.
Pomeranian Medical University · PL

Funding

Pomeranian Medical University in Szczecin WLBiMl-431-04/S/12/2017
6 · The paper itself

Abstract

backgroundAcanthamoebiasis is most often found in patients with immune deficiency, with infections facilitated by the intake of immunosuppressive drugs. The host immune response to Acanthamoeba spp. infection is poorly understood. Thus, in this study, we aimed to examine the course of Acanthamoeba spp. infection taking into account the host's immunological status, including assessment of the hematological parameters, cytokine analysis, immunophenotypic changes in spleen populations, and histological spleen changes, which could help clarify some aspects of the immune response to acanthamoebiasis. In our experimental study, we used Acanthamoeba strain AM 22 isolated from the bronchoaspirate of a patient with acute myeloid leukaemia (AML) and atypical pneumonia symptoms.

resultsAcanthamoeba spp. affected the hematological parameters in immunocompetent and immunosuppressed mice and induced a change in spleen weight during infection. Moreover, analysis of anti-inflammatory (IL-4 and IL-10) and pro-inflammatory (IL-17A and IFN-γ) cytokines produced by splenocytes stimulated with concanavalin A demonstrated that Acanthamoeba spp. induced a selective Th1, Th2 and Th17 response at later stages of the infection in immunocompetent hosts. In the case of hosts with low immunity, Acanthamoeba elicited robust Th1 cell-mediated immunity without the participation of Th17. We observed suppression of CD8+ and CD4+ T lymphocytes and CD3+CD4-CD8- double-negative (DN) T lymphocyte populations in the beginning, and in the case of CD3+/CD4+/CD8+ double-positive (DP) T cells in the final phase of Acanthamoeba spp. infection in hosts with low immunity. Also, CD4+T lymphocytes and CD3+/CD4+ and CD3+/CD8+ lymphocyte counts during each stage of acanthamoebiasis were shown to be upregulated.

conclusionsWe demonstrated that analysis of the immune response and pathogenesis mechanisms of clinical isolates of Acanthamoeba spp. in an animal model not only has purely cognitive significance but above all, may help in the development of effective methods of pharmacological therapy especially in patients with low immunity.

Indexed as

Immunity, CellularAcanthamoebaAmebiasisAnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCytokinesDisease Models, AnimalHumansImmunocompetenceImmunocompromised HostImmunophenotypingMaleMiceMice, Inbred BALB CMiddle AgedCytokinesAcanthamoeba spp.Immunological statusImmunophenotype

Identifiers

PMID30236160
PMCPMC6149055
OpenAlexW2890658874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.